GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Cash from Investing Activities came in at -$115.0 million in Q2 2026, up 48.43% YoY from -$77.5 million in Q2 2025, and up 95.4% on a QoQ basis from -$2.5 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Cash from Investing Activities data on file, last reported at -$115.0 million in Q2 2026.
- Quarterly Cash from Investing Activities rose 48.43% year-over-year to -$115.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.0 billion (down 201.09% YoY) and the FY2025 annual result came in at -$1.0 billion, down 14.55% from the prior year.
- Cash from Investing Activities advanced to -$115.0 million in Q2 2026, from -$2.5 billion in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$84.0 million in Q2 2023 to a low of -$2.5 billion in Q1 2026.
- A 5-year average of -$307.3 million and a median of -$142.5 million in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 48.43% in 2026, down 514.25% in 2026.
- Tracing GEHC's Cash from Investing Activities over 5 years: stood at -$95.0 million in 2022, then grew by 7.37% to -$88.0 million in 2023, then tumbled by 172.73% to -$240.0 million in 2024, then dropped by 12.08% to -$269.0 million in 2025, then soared by 57.25% to -$115.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$115.0 million (Q2 2026), -$2.5 billion (Q1 2026), and -$269.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -115.00 Mn |
| Jun 30, 2026 | -115.00 Mn |
| Mar 31, 2026 | -2.50 Bn |
| Mar 31, 2026 | -2.50 Bn |
| Dec 31, 2025 | -269.00 Mn |
| Dec 31, 2025 | -269.00 Mn |
| Sep 30, 2025 | -148.00 Mn |
| Sep 30, 2025 | -148.00 Mn |
| Jun 30, 2025 | -223.00 Mn |
| Jun 30, 2025 | -223.00 Mn |
| Mar 31, 2025 | -407.00 Mn |
| Mar 31, 2025 | -407.00 Mn |
| Dec 31, 2024 | -240.00 Mn |
| Dec 31, 2024 | -240.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -349.00 Mn |
| Jun 30, 2024 | -349.00 Mn |
| Mar 31, 2024 | -188.00 Mn |
| Mar 31, 2024 | -188.00 Mn |